Charter Oak Capital Management, LLC Bio N Tech Se Transaction History
Charter Oak Capital Management, LLC
- $1.09 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.5MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$856 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$447 Million0.39% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$444 Million1.71% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$197 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$188 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...